MANNKIND CORP Uncategorized Contracts & Agreements

40 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated March 25, 2024, between MannKind Corporation and Chris Prentiss
MANNKIND CORP
Biotechnology
2024
Offer Letter, dated May 16, 2023, by and between MannKind Corporation and Sanjay Singh
MANNKIND CORP
Biotechnology
2024
Offer Letter, dated September 19, 2022, by and between MannKind Corporation and Burkhard Blank
MANNKIND CORP
Biotechnology
2024
Offer Letter, dated March 21, 2023, by and between MannKind Corporation and Lauren M. Sabella
MANNKIND CORP
Biotechnology
2023
Offer Letter, dated August 11, 2003, by and between MannKind and Joseph Kocinsky
MANNKIND CORP
Biotechnology
2021
Offer Letter, dated May 7, 2020 by and between MannKind and Alejandro Galindo
MANNKIND CORP
Biotechnology
2021
Research Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics Corporation
MANNKIND CORP
Biotechnology
WA
2018
Offer Letter dated February 2, 2018, by and between MannKind and David Kendall
MANNKIND CORP
Biotechnology
2018
Offer Letter dated June 28, 2017, by and between MannKind and Patrick McCauley
MANNKIND CORP
Biotechnology
2018
Offer Letter dated February 17, 2017, by and between MannKind and Courtney Barton
MANNKIND CORP
Biotechnology
2018
EX-101 INSTANCE DOCUMENT
MANNKIND CORP
Biotechnology
NY
2011
EX-101 INSTANCE DOCUMENT
MANNKIND CORP
Biotechnology
CA
2011
OMNI CAPITAL CORPORATION 119 West 72nd Street Suite 283 33 West Main Street POB 390New York, NY 10023 Oyster Bay, NY 11771 Mr. Matthew J. Pfeffer August 10, 2010Chief Financial...
MANNKIND CORP
Biotechnology
NY
2010
7,400,000 Shares
MANNKIND CORP
Biotechnology
2009
Current assets
MANNKIND CORP
Biotechnology
DE
2009
Current assets
MANNKIND CORP
Biotechnology
NY
2009
Current assets
MANNKIND CORP
Biotechnology
CT
2007
MANNKIND CORPORATION
MANNKIND CORP
Biotechnology
NY
2006
MANNKIND CORPORATION
MANNKIND CORP
Biotechnology
NY
2006
Current assets
MANNKIND CORP
Biotechnology
2006
Current assets
MANNKIND CORP
Biotechnology
CA
2006
Pro forma
MANNKIND CORP
Biotechnology
DE
2004
Consent of Deloitte & Touche LLP
MANNKIND CORP
Biotechnology
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
DE
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
DE
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
CA
2004
Technosphere Insulin approximation
MANNKIND CORP
Biotechnology
NY
2004